Information about Actos and bladder cancer.

Actos Recall

In June 2011, the Food and Drug Administration issued a warning that patients treated with the diabetes drug Actos may face an increased risk of developing bladder cancer. A warning label that was added to Actos following the FDA’s announcement states that patients who use Actos for more than one year are 40% more likely than non-users to be diagnosed with bladder cancer.

Despite multiple studies linking Actos to an increased risk of bladder cancer, the FDA has not announced any plans to recall Actos in the United States. The agency is currently evaluating the results of several studies concerning the link between Actos and bladder cancer and plans to update the public on its findings as more information becomes available.

Although the FDA has no current plans to issue an Actos recall, health officials in other countries have already ordered a stop to the sale of the drug. Following the results of a French Actos bladder cancer study, health officials in France and Germany halted domestic sale of the drug, citing the increased cancer risk uncovered by researchers.

If you or a loved one were diagnosed with bladder cancer after taking Actos—or if you have developed any symptoms of the disease—you may qualify to file a lawsuit. For a free legal evaluation of your rights, contact the lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.

Contact Us Today for a Free Consultation.

I am currently represented by an attorney.
*Required fields